Cardiologie [Cardiology]

Details

Ressource 1Download: 172-80_42323.pdf (642.53 [Ko])
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_7AE207FC0DDC
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Cardiologie [Cardiology]
Journal
Revue medicale suisse
Author(s)
Kilani N., Haddad C., Lu H., Ghanbari F., Domenichini G., Pavon A.G., Tzimas G., Fournier S., Hullin R., Pascale P., Eeckhout E., Schwitter J., Pruvot E., Bouchardy J., Monney P., Muller O., Rutz T.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
27/01/2021
Peer-reviewed
Oui
Volume
17
Number
723
Pages
172-180
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
In 2020, new guidelines have been published by the European Society of Cardiology including those on non-ST-segment elevation acute coronary syndromes, atrial fibrillation and adult congenital heart disease. Regarding interventional cardiology, POPular TAVI opens the possibility of anti-platelet monotherapy after transcutaneous aortic valve replacement. EMPEROR-Reduced confirms the importance of SGLT2 inhibitors in the treatment of heart failure with reduced ejection fraction. Within the field of imaging, stress MRI has now become the first-line technique for the screening of coronary artery disease, demonstrating an excellent cost-benefit ratio. Finally, renin-angiotensin-aldosterone inhibitors do not appear to increase the risk of an infection by COVID-19.
Keywords
COVID-19, Cardiology, Heart Defects, Congenital, Humans, SARS-CoV-2
Pubmed
Create date
04/09/2021 7:33
Last modification date
13/02/2022 7:36
Usage data